SPIO neuroimaging for glioma patients to visualize infiltration.
Phase 1
- Conditions
- Detection of extent of tumor infiltration in healty brain tissue in patients with glioblastoma using USPIO as a blood pool contrast agent.Therapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2023-000068-80-NL
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Aged between 18 and 75 years;
- diagnosed with suspected glioblastoma;
- eligible for neurosurgical resection and/or chemoradiation therapy.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 30
Exclusion Criteria
- Younger than 18 years old,
- patients unfit for surgery or lesions unsuitable for neurosurgical treatment.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method